» Articles » PMID: 14871257

Production of Interferon-gamma by Lymphocytes from Paroxysmal Nocturnal Haemoglobinuria Patients: Relationship with Clinical Status

Overview
Journal Br J Haematol
Specialty Hematology
Date 2004 Feb 12
PMID 14871257
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Paroxysmal nocturnal haemoglobinuria (PNH) is characterized by the expansion of phosphatidylinositol glycan class A (PIG-A) defective haematopoietic cells, probably due to the immune-mediated alterations of the bone marrow environment selecting PIG-A- stem cells. The present study investigated the presence of alterations of the immune system in a population of 11 PNH patients. The production of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2), evaluated by intracellular cytokine analysis, and the frequencies of class I and II human leucocyte antigen (HLA) alleles were studied in comparison with healthy human subjects. Similar percentages of lymphocytes produced cytokines in PNH patients and controls after costimulation-independent activation; however, a negative correlation was found between the percentage of IFN-gamma producing cells and white cell or platelets counts. PNH patients showed an higher percentage, compared with controls, of IFN-gamma producing cells after costimulation-dependent activation. The frequency of HLA-A31 was higher in patients than in controls (27.2% vs. 4%), similarly to that of HLA-B7 (27.2% vs. 6%). With regard to class II alleles, 18% of PNH patients expressed DQB1*04 compared with none of 50 control cases. This study supports the hypothesis that immune alteration are present in PNH and that the immunogenetic background could influence the development of the disease.

Citing Articles

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome in a patient with paroxysmal nocturnal hemoglobinuria: a case report.

Chen L, Shi X, Jin J, Han W, Qu L, Li W J Int Med Res. 2021; 49(5):3000605211013277.

PMID: 34000872 PMC: 8135219. DOI: 10.1177/03000605211013277.


Bone Marrow Failure Syndromes, Overlapping Diseases with a Common Cytokine Signature.

Giudice V, Cardamone C, Triggiani M, Selleri C Int J Mol Sci. 2021; 22(2).

PMID: 33445786 PMC: 7828244. DOI: 10.3390/ijms22020705.


Potential link between MHC-self-peptide presentation and hematopoiesis; the analysis of HLA-DR expression in CD34-positive cells and self-peptide presentation repertoires of MHC molecules associated with paroxysmal nocturnal hemoglobinuria.

Nowak J, Wozniak J, Mendek-Czajkowska E, Dlugokecka A, Mika-Witkowska R, Rogatko-Koros M Cell Biochem Biophys. 2012; 65(3):321-33.

PMID: 23076633 PMC: 3601265. DOI: 10.1007/s12013-012-9435-1.


New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.

Kawaguchi T, Nakakuma H Int J Hematol. 2007; 86(1):27-32.

PMID: 17675263 DOI: 10.1532/IJH97.07029.